A Chip Stock Gets Checked - Behind the Drop in Intel; and Gilead’s Remdesivir Gets the Green Light

episode

CNBC's "Fast Money" not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Who are the "passport bros" travelling abroad to find love? 5 min · 25 Sep 2026 · Do you really know?

Can plate colour really affect our sense of taste? 5 min · 25 Sep 2026 · Do you really know?

Is a white tongue unhealthy? 2 min · 25 Sep 2026 · Do you really know?

After 2 Years of Interviewing Health Experts, Here’s What I Actually Believe 58 min · 25 Sep 2026 · Culture Apothecary with Alex Clark

Picking Our England XI vs Spain 23 min · 25 Sep 2026 · The Rest Is Football

Jamie Lowther-Pinkerton 1h 23m · 25 Sep 2026 · Rosebud with Gyles Brandreth

Report any issue

Source

Recorded22 Oct 2020

Publisherfeeds.simplecast.com ↗

Handlerec:4942256

Show notes

Intel shares plunged after the company reported weak results for its data center group. What’s next for the stock that’s been far underperforming the rest of the semi sector. And Gilead gets FDA approval for remdesivir. We break down the rest of the race for a COVID vaccine. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in